TREANDA 25 MG Injection
- RxCUI
- 1805009
- RxNorm name
- TREANDA 25 MG Injection
- Display name
- TREANDA 25 MG Injection
- Full name
- TREANDA 25 MG Injection
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:54
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| TREANDA | BENDAMUSTINE HYDROCHLORIDE | Cephalon, LLC | 39d53698-57fa-7c99-fc5b-f52a55684826 | 2022-10-27 | Warnings, Adverse reactions | 1805009 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 39d53698-57fa-7c99-fc5b-f52a55684826 | TREANDA 25 MG Injection | PSN | 26 | These highlights do not include all the information needed to use TREANDA safely and effectively. See full prescribing information for TREANDA. TREANDA ® (bendamustine hydrochloride) injection, for intravenous use TREANDA ® (bendamustine hydrochloride) for injection, for intravenous use Initial U.S. Approval: 2008 | 20221027 |
| 39d53698-57fa-7c99-fc5b-f52a55684826 | Treanda 25 MG Injection | SY | 26 | These highlights do not include all the information needed to use TREANDA safely and effectively. See full prescribing information for TREANDA. TREANDA ® (bendamustine hydrochloride) injection, for intravenous use TREANDA ® (bendamustine hydrochloride) for injection, for intravenous use Initial U.S. Approval: 2008 | 20221027 |
| 39d53698-57fa-7c99-fc5b-f52a55684826 | bendamustine hydrochloride 25 MG Injection [Treanda] | SBD | 26 | These highlights do not include all the information needed to use TREANDA safely and effectively. See full prescribing information for TREANDA. TREANDA ® (bendamustine hydrochloride) injection, for intravenous use TREANDA ® (bendamustine hydrochloride) for injection, for intravenous use Initial U.S. Approval: 2008 | 20221027 |